HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearchCompany Lookup

Drugs, Discounts and Data: Crafting Sustainability in an Imperfect System

Today's guest post comes from Angie Franks, Chief Executive Officer at Kalderos. As Angie explains, the industry still lacks the transparency needed to effectively manage where discounts occur and how funds move across stakeholders. She argues that improving visibility and coordination across the ec

By Drug Channels · May 29, 2026 · via Drug Channels

This is an aggregated industry headline. Read the full story at Drug Channels

RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.

Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Insulet and Calm are integrating mental health care into diabetes treatment with a series of mindfulness, medi…
Jul 14, 2026
The WeekFierceBiotech ↗
Spero Therapeutics is pivoting to immune and inflammation indications through a license agreement for a CD40L …
Jul 14, 2026
GSK Eyes FDA Nod for Jemperli in Targeted Rectal Cancer After Phase 2 Win
The WeekBriefing
Jemperli met its main goal in a phase 2 trial for certain rectal cancers, and GSK now plans to seek U.S. appro…
Jul 14, 2026